Every SEC Form 3/4/5 on record for this filer (CIK 1294192) — 2 issuers, 84 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | Chief Operating Officer | 2020-02-12 → 2026-06-17 | 43 | −$37M |
| SGMO | SANGAMO THERAPEUTICS, INC | Director | 2022-12-19 → 2025-06-16 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RVMD | 2026-06-17 | Sell | 29,600 | $160.12 | $5M | 154,647 |
| RVMD | 2026-06-15 | Sell | 60,400 | $160.17 | $10M | 158,222 |
| RVMD | 2026-06-11 | Sell | 500 | $147.27 | $73,635 | 164,822 |
| RVMD | 2026-06-11 | Sell | 200 | $150.17 | $30,034 | 158,222 |
| RVMD | 2026-06-11 | Sell | 4,600 | $149.64 | $688,344 | 158,422 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.